CRN: FDA’s ‘arbitrary and capricious decision making’ on phytosterol claims has put supplements industry in an ‘untenable’ position
The Food and Drug Administration (FDA) has put supplement makers in an “untenable” position with its move to discontinue an eight-year-old policy of enforcement discretion on health claims about phytosterols, according to the Council for Responsible...